Prevalence, correlates, and disease patterns of antidepressant use in Taiwan

Comprehensive Psychiatry

Volumn 52, Issue 6, 2011, Pages 662-669

  Kuo, Chien Cheng ^a,b   Chien, I Chia ^b,c   Lin, Ching Heng ^d   Lee, Wen Guang ^a   Chou, Yiing Jenq ^b   Lee, Cheng Hua ^b,e   Chou, Pesus ^b  

^a Jianan Mental Hospital   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Taoyuan Mental Hospital   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e Bureau of National Health Insurance Taiwan   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; DRUG COST; DYSTHYMIA; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRESCRIPTION; PREVALENCE; TAIWAN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; SEX FACTORS; SOCIOECONOMIC FACTORS; TAIWAN; YOUNG ADULT;

EID: 80054714023     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2011.01.002     Document Type: Article

References (58)

1. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., and Bryson H. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project Acta Psychiatr Scand Suppl 109 2004 55 64
2. Paulose-Ram R., Jonas B.S., Orwig D., and Safran M.A. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994 J Clin Epidemiol 57 2004 309 317 (Pubitemid 38456883)
3. Beck C.A., Williams J.V.A., Wang J.L., Kassam A., El-Guebaly N., and Currie S.R. Psychotropic medication use in Canada Can J Psychiatry 50 2005 605 613 (Pubitemid 43175499)
4. Weissman M.M., Bland R., Joyce P.R., Newman S., Wells J.E., and Wittchen H.U. Sex differences in rates of depression: cross-national perspectives J Affect Disord 29 1993 77 84 (Pubitemid 23334115)
5. Szádóczky E., Papp Z., Vitrai J., Ríhmer Z., and Füredi J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J Affect Disord 50 1998 153 162
6. Parikh S.V., Lam R.W. CANMAT Depression Work Group Clinical guidelines for the treatment of depressive disorders. I. Definitions, prevalence, and health burden Can J Psychiatry 46 2001 13 20
7. Ialongo N., McCreary B.K., Pearson J.L., Koenig A.L., Schmidt N.B., and Poduska J. Major depressive disorder in a population of urban, African-American young adults: prevalence, correlates, comorbidity and unmet mental health service need J Affect Disord 79 2004 127 136 (Pubitemid 38340536)
8. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 2005 593 602 (Pubitemid 40973434)
9. Hämäläinen J., Isometsä E., Laukkala T., Kaprio J., Poikolainen K., and Heikkinen M. Use of health services for major depressive episode in Finland J Affect Disord 79 2004 105 112 (Pubitemid 38340534)
10. Beck C.A., Patten S.B., Williams J.V., Wang J.L., Currie S.R., and Maxwell C.J. Antidepressant utilization in Canada Soc Psychiatry Psychiatr Epidemiol 40 2005 799 807 (Pubitemid 41600191)
11. Rosholm J.U., Hallas J., and Gram L.F. Outpatient utilization of antidepressants: a prescription database analysis J Affect Disord 27 1993 21 28 (Pubitemid 23029235)
12. Strothers H.S. III, Rust G., Minor P., Fresh E., Druss B., and Satcher D. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression J Am Geriatr Soc 53 2005 456 461 (Pubitemid 41623525)
13. Montagnier D., Barberger-Gateau P., Jacqmin-Gadda H., Dartigues J.F., Rainfray M., and Pérès K. Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: results from the personnes agees quid study J Am Geriatr Soc 54 2006 1839 1845 (Pubitemid 44915826)
14. Ufer M., Meyer S.A., Junge O., Selke G., Volz H.P., and Hedderich J. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis Pharmacoepidemiol Drug Saf 16 2007 1153 1160 (Pubitemid 350020070)
15. Melfi C.A., Croghan T.W., Hanna M.P., and Robinson R.L. Racial variation in antidepressant treatment in a Medicaid population J Clin Psychiatry 61 2000 16 21 (Pubitemid 30104378)
16. Raymond C.B., Morgan S.G., and Caetano P.A. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence Psychiatr Serv 58 2007 79 84
17. Sawynok J., Esser M.J., and Reid A.R. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action J Psychiatry Neurosci 26 2001 21 29 (Pubitemid 32185176)
18. Atkinson J.H., Slater M.A., Williams R.A., Zisook S., Patterson T.L., and Grant I. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain Pain 76 1998 287 296 (Pubitemid 28342738)
19. Atkinson J.H., Slater M.A., Wahlgren D.R., Williams R.A., Zisook S., and Pruitt S.D. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity Pain 83 1999 137 145 (Pubitemid 29479271)
20. Gallagher R.M., and Verma S. Managing pain and comorbid depression: a public health challenge Semin Clin Neuropsychiatry 4 1999 203 220
21. Jaeschke R., Adachi J., Guyatt G., Keller J., and Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials J Rheumatol 18 1991 447 451
22. Wolfe F., Cathey M.A., and Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia Scand J Rheumatol 23 1994 255 259 (Pubitemid 24334031)
23. Branco J.C. The diagnosis and treatment of fibromyalgia Acta Med Port 8 1995 233 238
24. Nørregaard J., Volkmann H., and Danneskiold-Samsøe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia Pain 61 1995 445 449
25. Arnold L.M., Hess E.V., Hudson J.I., Welge J.A., Berno S.E., and Keck P.E. Jr A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia Am J Med 112 2002 191 197
26. Steiner T.J., Ahmed F., Findley L.J., MacGregor E.A., and Wilkinson M. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study Cephalalgia 18 1998 283 286 (Pubitemid 28322625)
27. d'Amato C.C., Pizza V., Marmolo T., Giordano E., Alfano V., and Nasta A. Fluoxetine for migraine prophylaxis: a double-blind trial Headache 39 1999 716 719 (Pubitemid 30075079)
28. Loder E.W., and Biondi D.M. Off-label prescribing of drugs in specialty headache practice Headache 44 2004 636 641 (Pubitemid 38931893)
29. Sindrup S.H., Gram L.F., Brøsen K., Eshøj O., and Mogensen E.F. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms Pain 42 1990 135 144 (Pubitemid 20258898)
30. Waldinger M.D., Hengeveld M.W., Zwinderman A.H., and Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline J Clin Psychopharmacol 18 1998 274 281 (Pubitemid 28353869)
31. Kim S.W., and Paick J.S. Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation Urology 54 1999 544 547 (Pubitemid 29407036)
32. Grubb B.P., Samoil D., Kip K., and Brewster P. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents J Am Coll Cardiol 24 1994 490 494 (Pubitemid 24246553)
33. Di Girolamo E., Di Iorio C., Leonzio L., Barbone C., and Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 33 1999 1227 1230
34. Hwu H.G., Yeh E.K., and Chang L.Y. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule Acta Psychiatr Scand 79 1989 136 147
35. Chien I.C., Hsu J.H., Bih S.H., Lin C.H., Chou Y.J., and Lee C.H. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan Psychiatry Clin Neurosci 62 2008 677 684
36. WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology 2005 World Health Organization Oslo
37. Chinese Hospital Association ICD-9-CM English-Chinese dictionary 2000 Chinese Hospital Association Press Taipei
38. Chien I.C., Chou Y.J., Lin C.H., Bih S.H., and Chou P. Prevalence of psychiatric disorders among national health insurance enrollees in Taiwan Psychiatr Serv 55 2004 691 697 (Pubitemid 38720861)
39. Chien I.C., Kuo C.C., Bih S.H., Chou Y.J., Lin C.H., and Lee C.H. The prevalence and incidence of treated major depressive disorder among National Health Insurance enrollees in Taiwan, 1996 to 2003 Can J Psychiatry 52 2007 28 36
40. Larson M.J., Miller K., and Fleming K.J. Treatment with antidepressant medications in private health plans Adm Policy Ment Health 34 2007 116 126
41. Ballard C., Bannister C., Solis M., Oyebode F., and Wilcock G. The prevalence, associations and symptoms of depression amongst dementia sufferers J Affect Disord 36 1996 135 144 (Pubitemid 26040161)
42. Kaup B.A., Loreck D., Gruber-Baldini A.L., German P., Menon A.S., and Zimmerman S. Depression and its relationship to function and medical status, by dementia status, in nursing home admissions Am J Geriatr Psychiatry 15 2007 438 442
43. Sihvo S., Isometsä E., Kiviruusu O., Hämäläinen J., Suvisaari J., and Perälä J. Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population J Affect Disord 110 2008 94 105
44. Johnson D.A. Studies of depressive symptoms in schizophrenia Br J Psychiatry 139 1981 89 100
45. Fawcett J., and Kravitz H.M. Anxiety syndromes and their relationship to depressive illness J Clin Psychiatry 44 1983 8 11 (Pubitemid 13037504)
46. Weinstock L.M., and Whisman M.A. Neuroticism as a common feature of the depressive and anxiety disorders: a test of the revised integrative hierarchical model in a national sample J Abnorm Psychol 115 2006 68 74
47. Feighner J.P. Overview of antidepressants currently used to treat anxiety disorders J Clin Psychiatry 60 Suppl 22 1999 18 22 (Pubitemid 30107951)
48. Zohar J., and Westenberg H.G. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors Acta Psychiatr Scand Suppl 403 2000 39 49
49. Sadock B.J. Kaplan & Sadock's synopsis of psychiatry 2003 Lippincott Williams & Wilkins Philadelphia
50. Hunsballe J.M., and Djurhuus J.C. Clinical options for imipramine in the management of urinary incontinence Urol Res 29 2001 118 125 (Pubitemid 32422513)
51. Hunsballe J.M., Rittig S., Pedersen E.B., Olesen O.V., and Djurhuus J.C. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria J Urol 158 1997 830 836
52. Longley K. Fibromyalgia: aetiology, diagnosis, symptoms and management Br J Nurs 15 2006 729 733
53. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management Int J Methods Psychiatr Res 12 2003 34 43 (Pubitemid 36675446)
54. Lin T.Y. Culture and psychiatry: a Chinese perspective Aust N Z J Psychiatry 16 1982 235 245 (Pubitemid 13129318)
55. Vasiuk Iu A., Nesterova E.A., Dovzhenko T.V., Kozina A.A., Sadulaeva I.A., and Tarasova K.V. Modern antidepressants in complex management of patients with hypertension and concomitant affective disorders Kardiologiia 44 2004 72 79
56. Swartz R., and Longwell P. Treatment of vertigo Am Fam Physician 71 2005 1115 1122 (Pubitemid 40395671)
57. Blakley B.W. Antidepressants and dizziness J Otolaryngol 28 1999 313 317
58. Ständer S., Böckenholt B., Schürmeyer-Horst F., Weishaupt C., Heuft G., and Luger T.A. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study Acta Derm Venereol 89 2009 45 51